ReP USP - Resultado da busca

Artigo de periodico
The FIGO ovulatory disorders classification system (2022)
Munro, Malcolm G.; Balen, Adam H.; Cho, SiHyun; Critchley, Hilary O. D.; Díaz, Ivonne; Ferriani, Rui Alberto; Henry, Laurie; Mocanu, Edgar; Spuy, Zephne M van der
Source: International Journal of Gynecology & Obstetrics. Unidade: FMRP
Subjects: OVULAÇÃO, SÍNDROME DO OVÁRIO POLICÍSTICO, GRAVIDEZ, DOENÇAS UTERINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNRO, Malcolm G. et al. The FIGO ovulatory disorders classification system. International Journal of Gynecology & Obstetrics, v. 159, n. 1, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.1002/ijgo.14331. Acesso em: 13 nov. 2024.
APA
Munro, M. G., Balen, A. H., Cho, S. H., Critchley, H. O. D., Díaz, I., Ferriani, R. A., et al. (2022). The FIGO ovulatory disorders classification system. International Journal of Gynecology & Obstetrics, 159( 1), 1-20. doi:10.1002/ijgo.14331
NLM
Munro MG, Balen AH, Cho SH, Critchley HOD, Díaz I, Ferriani RA, Henry L, Mocanu E, Spuy ZM van der. The FIGO ovulatory disorders classification system [Internet]. International Journal of Gynecology & Obstetrics. 2022 ; 159( 1): 1-20.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/ijgo.14331
Vancouver
Munro MG, Balen AH, Cho SH, Critchley HOD, Díaz I, Ferriani RA, Henry L, Mocanu E, Spuy ZM van der. The FIGO ovulatory disorders classification system [Internet]. International Journal of Gynecology & Obstetrics. 2022 ; 159( 1): 1-20.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/ijgo.14331
Artigo de periodico
Standardized statement for the ethical use of human cadaveric tissues in anatomy research papers: recommendations from Anatomical Journal Editors-in-Chief (2022)
Iwanaga, Joe; Singh, Vishram; Takeda, Sén; Ogeng'o, Julius; Kim, Hee‐Jin; Moryś, Janusz; Ravi, Kumar Satish; Ribatti, Domenico; Trainor, Paul A.; Sañudo, José Ramón; Apaydin, Nihal; Sharma, Anu; Smith, Heather F.; Walocha, Jerzy A.; Hegazy, Ahmed M. S.; Duparc, Fabrice; Paulsen, Friedrich; Del Sol, Mariano; Adds, Philip; Louryan, Stephane; Fazan, Valéria Paula Sassoli ; Boddeti, R. K.; Tubbs, R. Shane
Source: Clinical Anatomy. Unidade: FMRP
Subjects: ANATOMIA, CADÁVER, ÉTICA MÉDICA, PESQUISA CIENTÍFICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IWANAGA, Joe et al. Standardized statement for the ethical use of human cadaveric tissues in anatomy research papers: recommendations from Anatomical Journal Editors-in-Chief. Clinical Anatomy, v. 35, n. 4, p. 526-528, 2022Tradução . . Disponível em: https://doi.org/10.1002/ca.23849. Acesso em: 13 nov. 2024.
APA
Iwanaga, J., Singh, V., Takeda, S., Ogeng'o, J., Kim, H. ‐J., Moryś, J., et al. (2022). Standardized statement for the ethical use of human cadaveric tissues in anatomy research papers: recommendations from Anatomical Journal Editors-in-Chief. Clinical Anatomy, 35( 4), 526-528. doi:10.1002/ca.23849
NLM
Iwanaga J, Singh V, Takeda S, Ogeng'o J, Kim H‐J, Moryś J, Ravi KS, Ribatti D, Trainor PA, Sañudo JR, Apaydin N, Sharma A, Smith HF, Walocha JA, Hegazy AMS, Duparc F, Paulsen F, Del Sol M, Adds P, Louryan S, Fazan VPS, Boddeti RK, Tubbs RS. Standardized statement for the ethical use of human cadaveric tissues in anatomy research papers: recommendations from Anatomical Journal Editors-in-Chief [Internet]. Clinical Anatomy. 2022 ; 35( 4): 526-528.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/ca.23849
Vancouver
Iwanaga J, Singh V, Takeda S, Ogeng'o J, Kim H‐J, Moryś J, Ravi KS, Ribatti D, Trainor PA, Sañudo JR, Apaydin N, Sharma A, Smith HF, Walocha JA, Hegazy AMS, Duparc F, Paulsen F, Del Sol M, Adds P, Louryan S, Fazan VPS, Boddeti RK, Tubbs RS. Standardized statement for the ethical use of human cadaveric tissues in anatomy research papers: recommendations from Anatomical Journal Editors-in-Chief [Internet]. Clinical Anatomy. 2022 ; 35( 4): 526-528.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/ca.23849
Artigo de periodico
TMPRSS11a is a novel age‐altered, tissue specific regulator of migration and wound healing (2021)
Fernandez, Christian; Burgos, Andres; Morales, Diego; Rosales‐Rojas, Roberto; Canelo, Javiera; Vergara‐Jaque, Ariela; Vieira, Gabriel Viliod ; Silva, Rodrigo Alberto Alves da; Sales, Katiuchia Uzzun ; Conboy, Michael J.; Bae, Eun Ji; Park, Kang‐Sik; Torres, Vicente A.; Garrido, Mauricio; Cerda, Oscar; Conboy, Irina M.; Cáceres, Mónica
Source: The FASEB Journal. Unidades: HU, FMRP
Subjects: ENVELHECIMENTO, PROLIFERAÇÃO CELULAR, FIBROBLASTOS, GENGIVA, TRANSDUÇÃO DE SINAL CELULAR, PELE, CICATRIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDEZ, Christian et al. TMPRSS11a is a novel age‐altered, tissue specific regulator of migration and wound healing. The FASEB Journal, v. 35, n. 5, 2021Tradução . . Disponível em: https://doi.org/10.1096/fj.202002253RRR. Acesso em: 13 nov. 2024.
APA
Fernandez, C., Burgos, A., Morales, D., Rosales‐Rojas, R., Canelo, J., Vergara‐Jaque, A., et al. (2021). TMPRSS11a is a novel age‐altered, tissue specific regulator of migration and wound healing. The FASEB Journal, 35( 5). doi:10.1096/fj.202002253RRR
NLM
Fernandez C, Burgos A, Morales D, Rosales‐Rojas R, Canelo J, Vergara‐Jaque A, Vieira GV, Silva RAA da, Sales KU, Conboy MJ, Bae EJ, Park K‐S, Torres VA, Garrido M, Cerda O, Conboy IM, Cáceres M. TMPRSS11a is a novel age‐altered, tissue specific regulator of migration and wound healing [Internet]. The FASEB Journal. 2021 ; 35( 5):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1096/fj.202002253RRR
Vancouver
Fernandez C, Burgos A, Morales D, Rosales‐Rojas R, Canelo J, Vergara‐Jaque A, Vieira GV, Silva RAA da, Sales KU, Conboy MJ, Bae EJ, Park K‐S, Torres VA, Garrido M, Cerda O, Conboy IM, Cáceres M. TMPRSS11a is a novel age‐altered, tissue specific regulator of migration and wound healing [Internet]. The FASEB Journal. 2021 ; 35( 5):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1096/fj.202002253RRR
Artigo de periodico
CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice (2020)
Wang, Chih-Hao; Lundh, Morten; Fu, Accalia; Kriszt, Rókus; Huang, Tian Lian; Lynes, Matthew D.; Leiria, Luiz Osório Silveira ; Shamsi, Farnaz; Darcy, Justin; Greenwood, Bennett P.; Narain, Niven R.; Tolstikov, Vladimir; Smith, Kyle L.; Emanuelli, Brice; Chang, Young-Tae; Hagen, Susan; Danial, Nika N.; Kiebish, Michael A.; Tseng, Yu-Hua
Source: Science Translational Medicine. Unidade: FMRP
Subjects: TECIDO ADIPOSO, DIETA, OBESIDADE, TERMOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Chih-Hao et al. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine, v. 12, n. 558, 2020Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aaz8664. Acesso em: 13 nov. 2024.
APA
Wang, C. -H., Lundh, M., Fu, A., Kriszt, R., Huang, T. L., Lynes, M. D., et al. (2020). CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine, 12( 558). doi:10.1126/scitranslmed.aaz8664
NLM
Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LOS, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang Y-T, Hagen S, Danial NN, Kiebish MA, Tseng Y-H. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice [Internet]. Science Translational Medicine. 2020 ; 12( 558):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1126/scitranslmed.aaz8664
Vancouver
Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LOS, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang Y-T, Hagen S, Danial NN, Kiebish MA, Tseng Y-H. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice [Internet]. Science Translational Medicine. 2020 ; 12( 558):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1126/scitranslmed.aaz8664
Artigo de periodico
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study (2020)
Swain, Sandra M.; Miles, David; Kim, Sung Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva M.; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefanía; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C.; Cortés, Javier; Andrade, Jurandyr Moreira de
Source: The Lancet Oncology. Unidade: FMRP
Subjects: ANTICORPOS MONOCLONAIS, PROTOCOLOS CLÍNICOS, QUIMIOTERAPIA COMBINADA, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, MÉTODO DUPLO-CEGO, METÁSTASE NEOPLÁSICA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SWAIN, Sandra M. et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. The Lancet Oncology, v. 21, n. 4, p. 519-530, 2020Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(19)30863-0. Acesso em: 13 nov. 2024.
APA
Swain, S. M., Miles, D., Kim, S. B., Im, Y. -H., Im, S. -A., Semiglazov, V., et al. (2020). Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. The Lancet Oncology, 21( 4), 519-530. doi:10.1016/S1470-2045(19)30863-0
NLM
Swain SM, Miles D, Kim SB, Im Y-H, Im S-A, Semiglazov V, Ciruelos EM, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J, Andrade JM de. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study [Internet]. The Lancet Oncology. 2020 ; 21( 4): 519-530.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/S1470-2045(19)30863-0
Vancouver
Swain SM, Miles D, Kim SB, Im Y-H, Im S-A, Semiglazov V, Ciruelos EM, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J, Andrade JM de. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study [Internet]. The Lancet Oncology. 2020 ; 21( 4): 519-530.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/S1470-2045(19)30863-0
Artigo de periodico
Assessing specialized metabolite diversity of Alnus species by a digitized LC–MS/MS data analysis workflow (2020)
Kang, Kyo Bin; Woo, Sunmin; Ernst, Madeleine; van der Hooft, Justin J. J.; Nothias, Louis-Félix; Silva, Ricardo Roberto da ; Dorrestein, Pieter C.; Sung, Sang Hyun; Lee, Mina
Source: Phytochemistry. Unidade: FMRP
Subjects: FITOQUÍMICA, METABÓLITOS, EXTRATOS (FORMAS FARMACÊUTICAS), ANÁLISE DE DADOS, PRODUTOS NATURAIS, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANG, Kyo Bin et al. Assessing specialized metabolite diversity of Alnus species by a digitized LC–MS/MS data analysis workflow. Phytochemistry, v. 173, p. 1-10, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.phytochem.2020.112292. Acesso em: 13 nov. 2024.
APA
Kang, K. B., Woo, S., Ernst, M., van der Hooft, J. J. J., Nothias, L. -F., Silva, R. R. da, et al. (2020). Assessing specialized metabolite diversity of Alnus species by a digitized LC–MS/MS data analysis workflow. Phytochemistry, 173, 1-10. doi:10.1016/j.phytochem.2020.112292
NLM
Kang KB, Woo S, Ernst M, van der Hooft JJJ, Nothias L-F, Silva RR da, Dorrestein PC, Sung SH, Lee M. Assessing specialized metabolite diversity of Alnus species by a digitized LC–MS/MS data analysis workflow [Internet]. Phytochemistry. 2020 ; 173 1-10.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.phytochem.2020.112292
Vancouver
Kang KB, Woo S, Ernst M, van der Hooft JJJ, Nothias L-F, Silva RR da, Dorrestein PC, Sung SH, Lee M. Assessing specialized metabolite diversity of Alnus species by a digitized LC–MS/MS data analysis workflow [Internet]. Phytochemistry. 2020 ; 173 1-10.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.phytochem.2020.112292
Artigo de periodico
Interaction of blood pressure lowering and alteplase dose in acute ischemic stroke: results of the enhanced control of hypertension and thrombolysis stroke study (2019)
Wang, Xia; Song, Lili; Yang, Jie; Sun, Lingli; Moullaali, Tom J.; Sandset, Else Charlotte; Delcourt, Candice; Lindley, Richard I.; Robinson, Thompson G.; Minhas, Jatinder S.; Arima, Hisatomi; Chalmers, John; Kim, Jong S.; Sharma, Vijay ; Wang, Ji-Guang; Pontes Neto, Octávio Marques
Source: Cerebrovascular Diseases. Unidade: FMRP
Subjects: ACIDENTE VASCULAR CEREBRAL, ISQUEMIA CEREBRAL, HEMORRAGIA, PRESSÃO SANGUÍNEA, HIPERTENSÃO, TRANSTORNOS CEREBROVASCULARES, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Xia et al. Interaction of blood pressure lowering and alteplase dose in acute ischemic stroke: results of the enhanced control of hypertension and thrombolysis stroke study. Cerebrovascular Diseases, v. 48, n. 3-6, p. 207-216, 2019Tradução . . Disponível em: https://doi.org/10.1159/000504745. Acesso em: 13 nov. 2024.
APA
Wang, X., Song, L., Yang, J., Sun, L., Moullaali, T. J., Sandset, E. C., et al. (2019). Interaction of blood pressure lowering and alteplase dose in acute ischemic stroke: results of the enhanced control of hypertension and thrombolysis stroke study. Cerebrovascular Diseases, 48( 3-6), 207-216. doi:10.1159/000504745
NLM
Wang X, Song L, Yang J, Sun L, Moullaali T J, Sandset E C, Delcourt C, Lindley R I, Robinson T G, Minhas J S, Arima H, Chalmers J, Kim J S, Sharma V , Wang J-G, Pontes Neto OM. Interaction of blood pressure lowering and alteplase dose in acute ischemic stroke: results of the enhanced control of hypertension and thrombolysis stroke study [Internet]. Cerebrovascular Diseases. 2019 ; 48( 3-6): 207-216.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1159/000504745
Vancouver
Wang X, Song L, Yang J, Sun L, Moullaali T J, Sandset E C, Delcourt C, Lindley R I, Robinson T G, Minhas J S, Arima H, Chalmers J, Kim J S, Sharma V , Wang J-G, Pontes Neto OM. Interaction of blood pressure lowering and alteplase dose in acute ischemic stroke: results of the enhanced control of hypertension and thrombolysis stroke study [Internet]. Cerebrovascular Diseases. 2019 ; 48( 3-6): 207-216.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1159/000504745
Artigo de periodico
Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas (2018)
Valera, Elvis Terci; McConechy, Melissa K.; Gayden, Tenzin; Rivera, Barbara; Jones, David T. W.; Wittmann, Andrea; Han, HyeRim; Bareke, Eric; Nikbakht, Hamid; Mikael, Leonie; Queiroz, Rosane Gomes de Paula; Suazo, Veridiana Kiill; Phi, Ji Hoon; Kim, Seung-Ki; Park, Sung-Hye; Fukaya, Raita; Yum, Mi-Sun; Ko, Tae-Sung; Oliveira, Ricardo Santos de; Machado, Hélio Rubens; Brassesco, Maria Sol; Santos, Antônio Carlos dos; Simão, Gustavo Novelino; Ramalho, Leandra Naíra Zambelli; Neder, Luciano; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Majewski, Jacek; Jabado, Nada
Source: Acta Neuropathologica. Unidades: FMRP, FFCLRP
Subjects: DOENÇAS CEREBRAIS, GENÉTICA, CÉREBRO, NEUROLOGIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Elvis Terci et al. Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas. Acta Neuropathologica, v. 136, n. 4, p. 657-660, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00401-018-1898-8. Acesso em: 13 nov. 2024.
APA
Valera, E. T., McConechy, M. K., Gayden, T., Rivera, B., Jones, D. T. W., Wittmann, A., et al. (2018). Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas. Acta Neuropathologica, 136( 4), 657-660. doi:10.1007/s00401-018-1898-8
NLM
Valera ET, McConechy MK, Gayden T, Rivera B, Jones DTW, Wittmann A, Han HR, Bareke E, Nikbakht H, Mikael L, Queiroz RG de P, Suazo VK, Phi JH, Kim S-K, Park S-H, Fukaya R, Yum M-S, Ko T-S, Oliveira RS de, Machado HR, Brassesco MS, Santos AC dos, Simão GN, Ramalho LNZ, Neder L, Scrideli CA, Tone LG, Majewski J, Jabado N. Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas [Internet]. Acta Neuropathologica. 2018 ; 136( 4): 657-660.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00401-018-1898-8
Vancouver
Valera ET, McConechy MK, Gayden T, Rivera B, Jones DTW, Wittmann A, Han HR, Bareke E, Nikbakht H, Mikael L, Queiroz RG de P, Suazo VK, Phi JH, Kim S-K, Park S-H, Fukaya R, Yum M-S, Ko T-S, Oliveira RS de, Machado HR, Brassesco MS, Santos AC dos, Simão GN, Ramalho LNZ, Neder L, Scrideli CA, Tone LG, Majewski J, Jabado N. Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas [Internet]. Acta Neuropathologica. 2018 ; 136( 4): 657-660.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00401-018-1898-8
Artigo de periodico
Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial (2018)
Minhas, Jatinder S.; Wang, Xia; Arima, Hisatomi; Bath, Philip M.; Billot, Laurent; Broderick, Joseph P.; Donnan, Geoffrey A.; Kim, Jong S.; Lavados, Pablo M.; Lee, Tsong-Hai; Martins, Sheila Cristina Ouriques; Olavarría, Verónica V.; Pandian, Jeyaraj D.; Pontes Neto, Octávio Marques; Ricci, Stefano; Sato, Shoichiro; Sharma, Vijay K.; Thang, Nguyen H.; Wang, Ji-Guang; Woodward, Mark; Chalmers, John; Anderson, Craig S.; Robinson, Thompson G.
Source: Cerebrovascular Diseases. Unidade: FMRP
Subjects: ACIDENTE VASCULAR CEREBRAL, TROMBOSE, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MINHAS, Jatinder S. et al. Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial. Cerebrovascular Diseases, v. 45, n. 5-6, p. 213-220, 2018Tradução . . Disponível em: https://doi.org/10.1159/000488911. Acesso em: 13 nov. 2024.
APA
Minhas, J. S., Wang, X., Arima, H., Bath, P. M., Billot, L., Broderick, J. P., et al. (2018). Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial. Cerebrovascular Diseases, 45( 5-6), 213-220. doi:10.1159/000488911
NLM
Minhas J S, Wang X, Arima H, Bath P M, Billot L, Broderick J P, Donnan G A, Kim J S, Lavados P M, Lee T-H, Martins SCO, Olavarría VV, Pandian J D, Pontes Neto OM, Ricci S, Sato S, Sharma V K, Thang N H, Wang J-G, Woodward M, Chalmers J, Anderson CS, Robinson TG. Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial [Internet]. Cerebrovascular Diseases. 2018 ; 45( 5-6): 213-220.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1159/000488911
Vancouver
Minhas J S, Wang X, Arima H, Bath P M, Billot L, Broderick J P, Donnan G A, Kim J S, Lavados P M, Lee T-H, Martins SCO, Olavarría VV, Pandian J D, Pontes Neto OM, Ricci S, Sato S, Sharma V K, Thang N H, Wang J-G, Woodward M, Chalmers J, Anderson CS, Robinson TG. Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial [Internet]. Cerebrovascular Diseases. 2018 ; 45( 5-6): 213-220.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1159/000488911
Artigo de periodico
Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017 (2018)
Gillessen, Silke; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bossi, Alberto; Bristow, Rob; Carver, Brett; Castellano, Daniel; Chung, Byung Ha; Clarke, Noel; Daugaard, Gedske; Davis, Ian D.; de Bono, Johann; Reis, Rodolfo Borges dos; Drake, Charles G.; Eeles, Ros; Efstathiou, Eleni; Evans, Christopher P.; Fanti, Stefano; Feng, Felix; Fizazi, Karim; Frydenberg, Mark; Gleave, Martin; Halabi, Susan; Heidenreich, Axel; Higano, Celestia S.; James, Nicolas
Source: European Urology. Unidade: FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GILLESSEN, Silke et al. Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017. European Urology, v. 73, n. 2, p. 178-211, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.eururo.2017.06.002. Acesso em: 13 nov. 2024.
APA
Gillessen, S., Attard, G., Beer, T. M., Beltran, H., Bossi, A., Bristow, R., et al. (2018). Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017. European Urology, 73( 2), 178-211. doi:10.1016/j.eururo.2017.06.002
NLM
Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, de Bono J, Reis RB dos, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James N. Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017 [Internet]. European Urology. 2018 ; 73( 2): 178-211.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.eururo.2017.06.002
Vancouver
Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, de Bono J, Reis RB dos, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James N. Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017 [Internet]. European Urology. 2018 ; 73( 2): 178-211.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.eururo.2017.06.002
Artigo de periodico
Heterogeneity within the PF-EPN-B ependymoma subgroup (2018)
Cavalli, Florence M. G.; Hübner, Jens-Martin; Sharma, Tanvi; Luu, Betty; Sill, Martin; Zapotocky, Michal; Mack, Stephen C.; Witt, Hendrik; Lin, Tong; Shih, David J. H.; Ho, Ben; Santi, Mariarita; Emery, Lyndsey; Hukin, Juliette; Dunham, Cristopher; McLendon, Roger E.; Lipp, Eric S.; Gururangan, Sridharan; Grossbach, Andrew; French, Pim; Kros, Johan M.; van Veelen, Marie-Lise C.; Rao, Amulya A. Nageswara; Giannini, Caterina; Leary, Sarah; Jung, Shin; Faria, Claudia C.; Mora, Jaume; Schüller, Ulrich; Alonso, Marta M.; Chan, Jennifer A.; Klekner, Almos; Chambless, Lola B.; Hwang, Eugene I.; Massimino, Maura; Eberhart, Charles G.; Karajannis, Matthias A.; Lu, Benjamin; Liau, Linda M.; Zollo, Massimo; Ferrucci, Veronica; Carlotti Júnior, Carlos Gilberto; Tirapelli, Daniela Pretti da Cunha; Tabori, Uri; Bouffet, Eric; Ryzhova, Marina; Ellison, David W.; Merchant, Thomas E.; Gilbert, Mark R.; Armstrong, Terri S.; Korshunov, Andrey; Pfister, Stefan M.; Taylor, Michael D.; Aldape, Kenneth; Pajtler, Kristian W.; Kool, Marcel; Ramaswamy, Vijay
Source: Acta Neuropathologica. Unidade: FMRP
Subjects: HETEROGENEIDADE, FOSSAS SÉPTICAS, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALLI, Florence M. G. et al. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica, v. 136, n. 2, p. 227-237, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00401-018-1888-x. Acesso em: 13 nov. 2024.
APA
Cavalli, F. M. G., Hübner, J. -M., Sharma, T., Luu, B., Sill, M., Zapotocky, M., et al. (2018). Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica, 136( 2), 227-237. doi:10.1007/s00401-018-1888-x
NLM
Cavalli FMG, Hübner J-M, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, McLendon RE, Lipp ES, Gururangan S, Grossbach A, French P, Kros JM, van Veelen M-LC, Rao AAN, Giannini C, Leary S, Jung S, Faria CC, Mora J, Schüller U, Alonso MM, Chan JA, Klekner A, Chambless LB, Hwang EI, Massimino M, Eberhart CG, Karajannis MA, Lu B, Liau LM, Zollo M, Ferrucci V, Carlotti Júnior CG, Tirapelli DP da C, Tabori U, Bouffet E, Ryzhova M, Ellison DW, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Pfister SM, Taylor MD, Aldape K, Pajtler KW, Kool M, Ramaswamy V. Heterogeneity within the PF-EPN-B ependymoma subgroup [Internet]. Acta Neuropathologica. 2018 ; 136( 2): 227-237.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00401-018-1888-x
Vancouver
Cavalli FMG, Hübner J-M, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, McLendon RE, Lipp ES, Gururangan S, Grossbach A, French P, Kros JM, van Veelen M-LC, Rao AAN, Giannini C, Leary S, Jung S, Faria CC, Mora J, Schüller U, Alonso MM, Chan JA, Klekner A, Chambless LB, Hwang EI, Massimino M, Eberhart CG, Karajannis MA, Lu B, Liau LM, Zollo M, Ferrucci V, Carlotti Júnior CG, Tirapelli DP da C, Tabori U, Bouffet E, Ryzhova M, Ellison DW, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Pfister SM, Taylor MD, Aldape K, Pajtler KW, Kool M, Ramaswamy V. Heterogeneity within the PF-EPN-B ependymoma subgroup [Internet]. Acta Neuropathologica. 2018 ; 136( 2): 227-237.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00401-018-1888-x
Artigo de periodico
Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication (2017)
Soares, Rodrigo Pedro; Xander, Patricia; Costa, Adriana Oliveira; Marcilla, Antonio; Menezes Neto, Armando; Del Portillo, Hernando; Witwer, Kenneth; Wauben, Marca; Nolte, Esther; Hoen, T; Olivier, Martin; Criado, Miriã Ferreira; Silva, Luis Lamberti Pinto da; Baqui, Munira Muhammad Abdel; Schenkman, Sergio; Colli, Walter ; Alves, Maria Júlia Manso ; Ferreira, Karen Spadari; Puccia, Rosana; Nejsum, Peter; Riesbeck, Kristian; Stensballe, Allan; Hansen, Eline Palm; Jaular, Lorena Martin; Ovstebo, Reidun; Canal, Laura de la; Bergese, Paolo; Pereira-Chioccola, Vera; Pfaffl, Michael W; Fritz, Joëlle; Gho, Yong Song; Torrecilhas, Ana Claudia
Source: Journal of Extracellular Vesicles. Unidades: FMRP, IQ
Subjects: DOENÇAS INFECCIOSAS, PATOLOGIA, INTERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Rodrigo Pedro et al. Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication. Journal of Extracellular Vesicles, v. 6, n. 1, p. 1-10 art. 1407213, 2017Tradução . . Disponível em: https://doi.org/10.1080/20013078.2017.1407213. Acesso em: 13 nov. 2024.
APA
Soares, R. P., Xander, P., Costa, A. O., Marcilla, A., Menezes Neto, A., Del Portillo, H., et al. (2017). Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication. Journal of Extracellular Vesicles, 6( 1), 1-10 art. 1407213. doi:10.1080/20013078.2017.1407213
NLM
Soares RP, Xander P, Costa AO, Marcilla A, Menezes Neto A, Del Portillo H, Witwer K, Wauben M, Nolte E, Hoen T, Olivier M, Criado MF, Silva LLP da, Baqui MMA, Schenkman S, Colli W, Alves MJM, Ferreira KS, Puccia R, Nejsum P, Riesbeck K, Stensballe A, Hansen EP, Jaular LM, Ovstebo R, Canal L de la, Bergese P, Pereira-Chioccola V, Pfaffl MW, Fritz J, Gho YS, Torrecilhas AC. Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication [Internet]. Journal of Extracellular Vesicles. 2017 ; 6( 1): 1-10 art. 1407213.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1080/20013078.2017.1407213
Vancouver
Soares RP, Xander P, Costa AO, Marcilla A, Menezes Neto A, Del Portillo H, Witwer K, Wauben M, Nolte E, Hoen T, Olivier M, Criado MF, Silva LLP da, Baqui MMA, Schenkman S, Colli W, Alves MJM, Ferreira KS, Puccia R, Nejsum P, Riesbeck K, Stensballe A, Hansen EP, Jaular LM, Ovstebo R, Canal L de la, Bergese P, Pereira-Chioccola V, Pfaffl MW, Fritz J, Gho YS, Torrecilhas AC. Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication [Internet]. Journal of Extracellular Vesicles. 2017 ; 6( 1): 1-10 art. 1407213.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1080/20013078.2017.1407213
Trabalho de evento-anais periodico
Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition (2016)
Ferguson, Lynnette R.; De Caterina, Raffaele; Görman, Ulf; Allayee, Hooman; Kohlmeier, Martin; Prasad, Chandan; Choi, Myung Sook; Curi, Rui; Luis, Daniel Antonio de; Gil, Angel; Kang, Jing X.; Martin, Ron L.; Milagro, Fermin I.; Nicoletti, Carolina Ferreira; Nonino, Carla Barbosa
Source: Journal of Nutregenetics and Nutregenomics. Conference titles: Congress of the International Society of Nutrigenetics/Nutrigenomics. Unidades: ICB, FMRP
Subjects: NUTRIGENÔMICA, NUTRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERGUSON, Lynnette R. et al. Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition. Journal of Nutregenetics and Nutregenomics. Basel: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1159/000445350. Acesso em: 13 nov. 2024. , 2016
APA
Ferguson, L. R., De Caterina, R., Görman, U., Allayee, H., Kohlmeier, M., Prasad, C., et al. (2016). Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition. Journal of Nutregenetics and Nutregenomics. Basel: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1159/000445350
NLM
Ferguson LR, De Caterina R, Görman U, Allayee H, Kohlmeier M, Prasad C, Choi MS, Curi R, Luis DA de, Gil A, Kang JX, Martin RL, Milagro FI, Nicoletti CF, Nonino CB. Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition [Internet]. Journal of Nutregenetics and Nutregenomics. 2016 ; 9 12-27.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1159/000445350
Vancouver
Ferguson LR, De Caterina R, Görman U, Allayee H, Kohlmeier M, Prasad C, Choi MS, Curi R, Luis DA de, Gil A, Kang JX, Martin RL, Milagro FI, Nicoletti CF, Nonino CB. Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition [Internet]. Journal of Nutregenetics and Nutregenomics. 2016 ; 9 12-27.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1159/000445350
Artigo de periodico
Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics (2016)
Lonn, Eva; Bosch, Jackie; Pogue, Janice; Avezum, Alvaro; Chazova, Irina; Dans, Antonio; Diaz, Rafael; Fodor, George J.; Held, Claes; Jansky, Petr; Keltai, Matyas; Keltai, Katalin; kunti, Kamlesh; Kim, Jae-Hyung; Leiter, Lawrence; Lewis, Basil; Liu, Lisheng; Lopez-Jaramillo, Patricio; Pais, Prem; Parkhomenko, Alexandr; Peters, Ron J. G; Piegas, Leopoldo S; Reid, Christopher M; Sliwa, Karen; Toff, William D; Varigos, John; Xavier, Denis; Yusoff, Khalid; Zhu, Jun; Dagenais, Gilles; Yusuf, Salim; Marin Neto, José Antonio
Source: Canadian Journal of Cardiology. Unidade: FMRP
Subjects: RECEPTORES DE ANGIOTENSINA, PRESSÃO SANGUÍNEA, DOENÇAS CARDIOVASCULARES, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LONN, Eva et al. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, v. 32, n. 3, p. 311-318, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.cjca.2015.07.001. Acesso em: 13 nov. 2024.
APA
Lonn, E., Bosch, J., Pogue, J., Avezum, A., Chazova, I., Dans, A., et al. (2016). Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, 32( 3), 311-318. doi:10.1016/j.cjca.2015.07.001
NLM
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Vancouver
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration